上市公司 Propanc Biopharma 计划收购 1 亿美元以太坊
ChainCatcher 消息，生物制药公司 Propanc Biopharma (纳斯达克股票代码: PPCB) 宣布计划在未来 12 个月内收购价值 1 亿美元的以太坊
该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略
风险提示 风险提示
关联标签
关联标签
扫码下载
BTC $67,356.19 -1.67%
ETH $1,940.93 -2.33%
BNB $611.69 -2.39%
XRP $1.42 -4.56%
SOL $81.67 -4.53%
TRX $0.2795 -0.47%
DOGE $0.0974 -3.83%
ADA $0.2735 -4.22%
BCH $568.94 +0.86%
LINK $8.64 -2.97%
HYPE $28.98 -1.81%
AAVE $122.61 -3.42%
SUI $0.9138 -6.63%
XLM $0.1605 -4.62%
ZEC $260.31 -8.86% BTC $67,356.19 -1.67% ETH $1,940.93 -2.33% BNB $611.69 -2.39% XRP $1.42 -4.56% SOL $81.67 -4.53% TRX $0.2795 -0.47% DOGE $0.0974 -3.83% ADA $0.2735 -4.22% BCH $568.94 +0.86% LINK $8.64 -2.97% HYPE $28.98 -1.81% AAVE $122.61 -3.42% SUI $0.9138 -6.63% XLM $0.1605 -4.62% ZEC $260.31 -8.86%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
